Treatment of type 2 diabetes (insulin‑independent) in adults, as a replacement for previous combination therapy of metformin and glibenclamide in patients whose glycaemia is stable and well‑controlled.
Treatment of type 2 diabetes (insulin‑independent) in adults, as a replacement for previous combination therapy of metformin and glibenclamide in patients whose glycaemia is stable and well‑controlled.